The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism
Abstract
We have analyzed the human mineralocorticoid receptor (hMR) gene in 14 families with autosomal dominant or sporadic pseudohypoaldosteronism (PHA1), a rare form of mineralocorticoid resistance characterized by neonatal renal salt wasting and failure to thrive. Six heterozygous mutations were detected. Two frameshift mutations in exon 2 (insT1354, del8bp537) and one nonsense mutation in exon 4 (C2157A, Cys645stop) generate truncated proteins due to premature stop codons. Three missense mutations (G633R, Q776R, L979P) differently affect hMR function. The DNA binding domain mutant R633 exhibits reduced maximal transactivation, although its binding characteristics and ED(50) of transactivation are comparable with wild-type hMR. Ligand binding domain mutants R776 and P979 present reduced or absent aldosterone binding, respectively, which is associated with reduced or absent ligand-dependent transactivation capacity. Finally, P979 possesses a transdominant negative effect on wild-type hMR activity, whereas mutations G633R and Q776R probably result in haploinsufficiency in PHA1 patients. We conclude that hMR mutations are a common feature of autosomal dominant PHA1, being found in 70% of our familial cases. Their absence in some families underscores the importance of an extensive investigation of the hMR gene and the role of precise diagnostic procedures to allow for identification of other genes potentially involved in the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autosomal dominant type 1 pseudohypoaldosteronism (PHAI) is caused by inactivating mutations in the mineralocorticoid receptor (642, 643).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [643]
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Nuclear Hormone Receptors and Gene Expression
Aranda, A., & Pascual, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1269 · Cited by 1,570
Krawczak, M., Reiss, J., & Cooper, D. (1992) · Human Genetics · doi:10.1007/bf00210743 · Cited by 1,324
A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes
Liu, H.-X., Cartegni, L., Zhang, M. Q., & Krainer, A. R. (2001) · Nature Genetics · doi:10.1038/83762 · Cited by 477
Geller, D. S., Rodriguez-Soriano, J., Boado, A. V., Schifter, S., Bayer, M., Chang, S. S., & Lifton, R. P. (1998) · Nature Genetics · doi:10.1038/966 · Cited by 417
Multiple aspects of mineralocorticoid selectivity
Farman, N., & Rafestin-Oblin, M.-E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f181 · Cited by 268
HANUKOGLU, A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-936 · Cited by 192
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Bledsoe, R. K., Madauss, K. P., Holt, J. A., Apolito, C. J., Lambert, M. H., Pearce, K. H., Stanley, T. B., Stewart, E. L., Trump, R. P., Willson, T. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504098200 · Cited by 218
Geller, D. S., Zhang, J., Zennaro, M., Vallo-Boado, A., Rodríguez‐Soriano, J., Furu, L., Haws, R. M., Metzger, D. L., Botelho, B., Karaviti, L. P., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111188 · Cited by 133
“Furthermore, two previously described patients with adPHA1 have MR mutations that are not carried by either parent, although formal genotyping to prove parental identity was not performed (7,8).”
BackgroundSelf-citationClinical and Molecular Features of Type 1 Pseudohypoaldosteronism
Riepe, F. G. (2009) · Hormone Research in Paediatrics · doi:10.1159/000224334 · Cited by 137
“Mutations in the LBD most often disturb aldosterone binding. Several variants associated with adPHA1 have been described. By the use of three-dimensional protein modeling the underlying structural disturbances have been delineated. This was especially useful for the functional characterization of different regions of…”
BackgroundOxidative Stress Causes Mineralocorticoid Receptor Activation in Rat Cardiomyocytes
Nagase, M., Ayuzawa, N., Kawarazaki, W., Ishizawa, K., Ueda, K., Yoshida, S., & Fujita, T. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185520 · Cited by 110
Metadata
- Authors
- Sartorato, P., Lapeyraque, A.-L., Armanini, D., Kuhnle, U., Khaldi, Y., Salomon, R., Abadie, V., Di Battista, E., Naselli, A., Racine, A., Bosio, M., Caprio, M., Poulet-Young, V., Chabrolle, J.-P., Niaudet, P., De Gennes, C., Lecornec, M.-H., Poisson, E., Fusco, A. M., Loli, P., Lombès, M., & Zennaro, M.-C.
- Affiliations
- University of Padua (IT)
- Hôpital Robert-Debré (FR)
- Ludwig-Maximilians-Universität München (DE)
- Inserm (FR)
- Division of Nephrology (R.S., P.N.), 75015 Paris, France
- Division of General Pediatrics (V.A.), Department of Pediatrics, Necker-Enfants Malades Hospital, 75015 Paris, France
- Institute G. Gaslini (E.D.B., A.N.), Division of Pediatrics I, 16148 Genova, Italy
- Istituto Giannina Gaslini (IT)
- Centro Diagnostico Italiano (IT)
- University of Rome Tor Vergata (IT)
- Division of Neonatology (V.P-Y., J.P.C.), Le Havre Hospital, 76083 Le Havre, France
- Groupe Hospitalier du Havre (FR)
- Division of Pediatrics (C.D.G.), Orsay General Hospital, 91405 Orsay, France
- Institut National de la Santé et de la Recherche Médicale, Unité 478, Faculté de Médecine Xavier Bichat (P.S., Y.K., M.-H.L., E.P., M.L., M.-C.Z.), 75018 Paris, France
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2508-2517
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2136975313
- Cited by
- 85
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 3 · 2012: 4
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- mineralocorticoid receptor, mineralocorticoid resistance, receptor mutations, frameshift mutation, nonsense mutation, missense mutations, DNA-binding domain, ligand-binding domain, transcriptional activation, haploinsufficiency, autosomal dominant inheritance, renal salt wasting, failure to thrive
- MeSH terms
- Female, Humans, Infant, Infant, Newborn, Male, Mutation, Pedigree, Pseudohypoaldosteronism, Transcription, Genetic, Cohort Studies, Receptors, Mineralocorticoid, Mutation, Missense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism. https://app.cochat.ai/papers/10.1210/jc.2002-021932
- The paper
- Sartorato, P., Lapeyraque, A.-L., Armanini, D., Kuhnle, U., Khaldi, Y., Salomon, R., Abadie, V., Di Battista, E., Naselli, A., Racine, A., Bosio, M., Caprio, M., Poulet-Young, V., Chabrolle, J.-P., Niaudet, P., De Gennes, C., Lecornec, M.-H., Poisson, E., Fusco, A. M., . . . Zennaro, M.-C. (2003). Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2002-021932
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.